Myocardial infarction is the first cause of worldwide mortality, with an increasing incidence
also reported in developing countries. Over the past decades, preclinical research and …

Background In recent years, cardiovascular disease in particular myocardial infarction (MI)
has become the predominant cause of human disability and mortality in the clinical setting …

Rationale: Systemic inflammation compromises the reparative properties of endothelial
progenitor cell (EPC) and their exosomes on myocardial repair, although the underlying …

Ischemic diseases are conditions associated with the restriction or blockage of blood supply
to specific tissues. These conditions can cause moderate to severe complications in …

Mesenchymal stem cell (MSC) transplantation after myocardial infarction (MI) has been
shown to effectively limit the infarct area in numerous clinical and preclinical studies …

Background This comprehensive systematic review and meta-analysis investigated the mid-
to long-term efficacy and safety of stem cell therapy in patients with acute myocardial …

Patients with chronic heart failure (HF) have a poor prognosis due to irreversible impairment
of left ventricular function, with 5-year survival rates< 60%. Despite advances in …

IMSC transplantation during CABG is considered one of the most promising methods to
effectively deliver stem cells and has been widely studied in many trials. But the results of …

Background and Purpose: Myocardial infarction (MI) in diabetic patients results in higher
mortality and morbidity. We and others have previously shown that bone marrow-endothelial …

There is growing interest in the regenerative potential of adipose-derived stem cells
(ADSCs) for wound healing applications. ADSCs have been shown to promote …